HEILBRUNN KENNETH R 5
5 · LA JOLLA PHARMACEUTICAL CO · Filed Feb 9, 2005
Insider Transaction Report
Form 5
HEILBRUNN KENNETH R
VP of Clinical Development
Transactions
- Other
Common Stock
2004-12-31$1.42/sh+554$786→ 11,028 total - Other
Common Stock
2004-06-30$1.48/sh+536$793→ 10,021 total - Other
Common Stock
2004-09-30$1.48/sh+453$670→ 10,474 total
Holdings
- 11,028
Common Stock
- 315,000
Stock Option (right to buy)
→ Common Stock (315,000 underlying)
Footnotes (2)
- [F1]Acquired pursuant to the Company?s Employee Stock Purchase Plan.
- [F2]Reporting only direct holdings, no transaction data is necessary